Business

Amgen buying deCODE Genetics for $415 million

By Linda Johnson
Published December 10, 2012 9:30pm ET
Add Washington Examiner on Google

TRENTON, N.J. (AP) — Biotech pioneer Amgen Inc., in a bid for a big edge in using people’s genetic information to find better ways to attack diseases, is buying human genetics research and analytics leader deCODE Genetics for $415 million.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.